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Letter to the Editor
Meta-analysis comparing higher and lower dose
radiotherapy for palliation in locally advanced lung
cancer
Cancer Sci 106 (2015) 782
doi: 10.1111/cas.12659
D ear Editor,In the context of an update of the Dutch guideline on
non-small-cell lung cancer, we performed a systematic review
on the clinical effectiveness of low-dose (i.e. <30 Gy) versus
high-dose palliative radiotherapy (i.e. ≥30 Gy). We identified
the recent meta-analysis of Ma et al.(1) that included five
randomized trials published until June 2013. Our systematic
review confirmed the completeness of the search of Ma et al.
However, when we examined the forest plot of the effect on
1-year overall survival, the Dutch trial of Kramer et al.(2) was
found to be discordant with the four other included studies.
Verification of the full-text publication confirmed that
Kramer’s results were wrongly extracted by Ma et al. (high-
dose, 11% instead of 20%; low-dose, 20% instead of 11%),
possibly resulting in an underestimation of the pooled effect
and wrong conclusions. We would like to ask the authors to
redo the meta-analysis with the correct data, and to recon-
sider the conclusions based on the new results.
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